Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EZH2
|
ENSG00000106462.6 | enhancer of zeste 2 polycomb repressive complex 2 subunit |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EZH2 | hg19_v2_chr7_-_148581251_148581347 | 0.48 | 1.6e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_-_72441315 | 8.68 |
ENST00000305425.4
ENST00000313174.7 ENST00000354591.4 |
DACH1
|
dachshund homolog 1 (Drosophila) |
chr4_-_16900242 | 6.40 |
ENST00000502640.1
ENST00000506732.1 |
LDB2
|
LIM domain binding 2 |
chr4_+_156588249 | 6.39 |
ENST00000393832.3
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr4_-_16900184 | 5.86 |
ENST00000515064.1
|
LDB2
|
LIM domain binding 2 |
chr4_-_16900217 | 5.67 |
ENST00000441778.2
|
LDB2
|
LIM domain binding 2 |
chr4_-_16900410 | 4.71 |
ENST00000304523.5
|
LDB2
|
LIM domain binding 2 |
chr4_+_156588115 | 4.70 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr5_+_175298573 | 3.74 |
ENST00000512824.1
|
CPLX2
|
complexin 2 |
chr13_-_72440901 | 3.38 |
ENST00000359684.2
|
DACH1
|
dachshund homolog 1 (Drosophila) |
chr14_-_54423529 | 3.00 |
ENST00000245451.4
ENST00000559087.1 |
BMP4
|
bone morphogenetic protein 4 |
chr6_+_142623063 | 2.41 |
ENST00000296932.8
ENST00000367609.3 |
GPR126
|
G protein-coupled receptor 126 |
chr4_+_156587979 | 2.40 |
ENST00000511507.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr4_+_156588350 | 2.34 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr1_+_61869748 | 2.33 |
ENST00000357977.5
|
NFIA
|
nuclear factor I/A |
chr8_+_97506033 | 2.32 |
ENST00000518385.1
|
SDC2
|
syndecan 2 |
chr10_-_116444371 | 2.26 |
ENST00000533213.2
ENST00000369252.4 |
ABLIM1
|
actin binding LIM protein 1 |
chr4_-_101439148 | 2.24 |
ENST00000511970.1
ENST00000502569.1 ENST00000305864.3 |
EMCN
|
endomucin |
chr4_-_101439242 | 2.09 |
ENST00000296420.4
|
EMCN
|
endomucin |
chr5_+_175298674 | 1.99 |
ENST00000514150.1
|
CPLX2
|
complexin 2 |
chr4_-_70626314 | 1.98 |
ENST00000510821.1
|
SULT1B1
|
sulfotransferase family, cytosolic, 1B, member 1 |
chr1_+_47489240 | 1.82 |
ENST00000371901.3
|
CYP4X1
|
cytochrome P450, family 4, subfamily X, polypeptide 1 |
chr9_+_133971863 | 1.75 |
ENST00000372309.3
|
AIF1L
|
allograft inflammatory factor 1-like |
chr4_+_126237554 | 1.70 |
ENST00000394329.3
|
FAT4
|
FAT atypical cadherin 4 |
chr9_+_133971909 | 1.65 |
ENST00000247291.3
ENST00000372302.1 ENST00000372300.1 ENST00000372298.1 |
AIF1L
|
allograft inflammatory factor 1-like |
chr19_+_51152702 | 1.64 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
chr6_+_53659746 | 1.62 |
ENST00000370888.1
|
LRRC1
|
leucine rich repeat containing 1 |
chr9_-_16727978 | 1.57 |
ENST00000418777.1
ENST00000468187.2 |
BNC2
|
basonuclin 2 |
chr7_+_150688166 | 1.57 |
ENST00000461406.1
|
NOS3
|
nitric oxide synthase 3 (endothelial cell) |
chr9_-_107690420 | 1.53 |
ENST00000423487.2
ENST00000374733.1 ENST00000374736.3 |
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1 |
chr7_+_102553430 | 1.50 |
ENST00000339431.4
ENST00000249377.4 |
LRRC17
|
leucine rich repeat containing 17 |
chr5_+_175298487 | 1.48 |
ENST00000393745.3
|
CPLX2
|
complexin 2 |
chr12_+_79258444 | 1.43 |
ENST00000261205.4
|
SYT1
|
synaptotagmin I |
chr12_+_79258547 | 1.43 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr9_-_14314566 | 1.42 |
ENST00000397579.2
|
NFIB
|
nuclear factor I/B |
chr3_+_193853927 | 1.37 |
ENST00000232424.3
|
HES1
|
hes family bHLH transcription factor 1 |
chr6_-_10415218 | 1.36 |
ENST00000466073.1
ENST00000498450.1 |
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr8_-_6420565 | 1.36 |
ENST00000338312.6
|
ANGPT2
|
angiopoietin 2 |
chr1_+_61330931 | 1.35 |
ENST00000371191.1
|
NFIA
|
nuclear factor I/A |
chrX_-_19688475 | 1.30 |
ENST00000541422.1
|
SH3KBP1
|
SH3-domain kinase binding protein 1 |
chr7_-_38671098 | 1.30 |
ENST00000356264.2
|
AMPH
|
amphiphysin |
chr4_-_159094194 | 1.29 |
ENST00000592057.1
ENST00000585682.1 ENST00000393807.5 |
FAM198B
|
family with sequence similarity 198, member B |
chr1_-_46598371 | 1.28 |
ENST00000372006.1
ENST00000425892.1 ENST00000420542.1 ENST00000354242.4 ENST00000340332.6 |
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
chr2_+_210288760 | 1.26 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
chr1_+_164528866 | 1.25 |
ENST00000420696.2
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
chr9_-_16728161 | 1.25 |
ENST00000603713.1
ENST00000603313.1 |
BNC2
|
basonuclin 2 |
chr1_+_61542922 | 1.23 |
ENST00000407417.3
|
NFIA
|
nuclear factor I/A |
chr12_+_93965451 | 1.23 |
ENST00000548537.1
|
SOCS2
|
suppressor of cytokine signaling 2 |
chr14_+_23846328 | 1.23 |
ENST00000382809.2
|
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5 |
chr9_-_14314518 | 1.23 |
ENST00000397581.2
|
NFIB
|
nuclear factor I/B |
chr12_+_93965609 | 1.22 |
ENST00000549887.1
ENST00000551556.1 |
SOCS2
|
suppressor of cytokine signaling 2 |
chr5_-_111093340 | 1.18 |
ENST00000508870.1
|
NREP
|
neuronal regeneration related protein |
chrX_+_28605516 | 1.16 |
ENST00000378993.1
|
IL1RAPL1
|
interleukin 1 receptor accessory protein-like 1 |
chr4_+_30721968 | 1.16 |
ENST00000361762.2
|
PCDH7
|
protocadherin 7 |
chr11_-_33891362 | 1.14 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr5_-_111092873 | 1.13 |
ENST00000509025.1
ENST00000515855.1 |
NREP
|
neuronal regeneration related protein |
chr11_-_44331679 | 1.11 |
ENST00000329255.3
|
ALX4
|
ALX homeobox 4 |
chr19_+_45973120 | 1.10 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr1_+_214161272 | 1.10 |
ENST00000498508.2
ENST00000366958.4 |
PROX1
|
prospero homeobox 1 |
chr10_+_94590910 | 1.07 |
ENST00000371547.4
|
EXOC6
|
exocyst complex component 6 |
chr8_-_4852494 | 1.07 |
ENST00000520002.1
ENST00000602557.1 |
CSMD1
|
CUB and Sushi multiple domains 1 |
chr1_-_46598284 | 1.06 |
ENST00000423209.1
ENST00000262741.5 |
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
chr2_-_188312971 | 1.05 |
ENST00000410068.1
ENST00000447403.1 ENST00000410102.1 |
CALCRL
|
calcitonin receptor-like |
chr2_+_11864458 | 1.04 |
ENST00000396098.1
ENST00000396099.1 ENST00000425416.2 |
LPIN1
|
lipin 1 |
chr5_+_121647877 | 1.03 |
ENST00000514497.2
ENST00000261367.7 |
SNCAIP
|
synuclein, alpha interacting protein |
chr8_-_6420759 | 1.03 |
ENST00000523120.1
|
ANGPT2
|
angiopoietin 2 |
chr2_+_28615669 | 1.01 |
ENST00000379619.1
ENST00000264716.4 |
FOSL2
|
FOS-like antigen 2 |
chr2_+_173686303 | 1.01 |
ENST00000397087.3
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr3_-_112360116 | 1.01 |
ENST00000206423.3
ENST00000439685.2 |
CCDC80
|
coiled-coil domain containing 80 |
chr17_+_61562201 | 1.00 |
ENST00000290863.6
ENST00000413513.3 ENST00000421982.2 |
ACE
|
angiotensin I converting enzyme |
chr17_+_7387677 | 0.99 |
ENST00000322644.6
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa |
chr8_-_4852218 | 0.99 |
ENST00000400186.3
ENST00000602723.1 |
CSMD1
|
CUB and Sushi multiple domains 1 |
chr8_-_6420777 | 0.99 |
ENST00000415216.1
|
ANGPT2
|
angiopoietin 2 |
chr4_+_123747834 | 0.98 |
ENST00000264498.3
|
FGF2
|
fibroblast growth factor 2 (basic) |
chr2_+_33172221 | 0.98 |
ENST00000354476.3
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr9_-_16870704 | 0.96 |
ENST00000380672.4
ENST00000380667.2 ENST00000380666.2 ENST00000486514.1 |
BNC2
|
basonuclin 2 |
chr5_-_35195338 | 0.94 |
ENST00000509839.1
|
PRLR
|
prolactin receptor |
chr4_+_74735102 | 0.94 |
ENST00000395761.3
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
chr10_+_30722866 | 0.94 |
ENST00000263056.1
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chr14_-_21270995 | 0.89 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr17_+_61562178 | 0.89 |
ENST00000490216.2
|
ACE
|
angiotensin I converting enzyme |
chr10_-_33623564 | 0.89 |
ENST00000374875.1
ENST00000374822.4 |
NRP1
|
neuropilin 1 |
chr11_-_34533257 | 0.87 |
ENST00000312319.2
|
ELF5
|
E74-like factor 5 (ets domain transcription factor) |
chrX_-_24665208 | 0.87 |
ENST00000356768.4
|
PCYT1B
|
phosphate cytidylyltransferase 1, choline, beta |
chr4_+_144257915 | 0.86 |
ENST00000262995.4
|
GAB1
|
GRB2-associated binding protein 1 |
chr2_+_169926047 | 0.86 |
ENST00000428522.1
ENST00000450153.1 ENST00000421653.1 |
DHRS9
|
dehydrogenase/reductase (SDR family) member 9 |
chr18_-_52969844 | 0.86 |
ENST00000561831.3
|
TCF4
|
transcription factor 4 |
chr5_-_88179302 | 0.85 |
ENST00000504921.2
|
MEF2C
|
myocyte enhancer factor 2C |
chr17_-_40575535 | 0.84 |
ENST00000357037.5
|
PTRF
|
polymerase I and transcript release factor |
chr9_+_75766763 | 0.83 |
ENST00000456643.1
ENST00000415424.1 |
ANXA1
|
annexin A1 |
chr17_+_61571746 | 0.82 |
ENST00000579409.1
|
ACE
|
angiotensin I converting enzyme |
chr16_+_30406721 | 0.82 |
ENST00000320159.2
|
ZNF48
|
zinc finger protein 48 |
chr5_+_140571902 | 0.82 |
ENST00000239446.4
|
PCDHB10
|
protocadherin beta 10 |
chr14_-_23285069 | 0.81 |
ENST00000554758.1
ENST00000397528.4 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr8_-_117043 | 0.80 |
ENST00000320901.3
|
OR4F21
|
olfactory receptor, family 4, subfamily F, member 21 |
chr1_+_367640 | 0.80 |
ENST00000426406.1
|
OR4F29
|
olfactory receptor, family 4, subfamily F, member 29 |
chr18_-_53177984 | 0.80 |
ENST00000543082.1
|
TCF4
|
transcription factor 4 |
chr3_-_197300194 | 0.78 |
ENST00000358186.2
ENST00000431056.1 |
BDH1
|
3-hydroxybutyrate dehydrogenase, type 1 |
chr14_-_23285011 | 0.77 |
ENST00000397532.3
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr2_+_33359687 | 0.76 |
ENST00000402934.1
ENST00000404525.1 ENST00000407925.1 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chrX_+_24711997 | 0.76 |
ENST00000379068.3
ENST00000379059.3 |
POLA1
|
polymerase (DNA directed), alpha 1, catalytic subunit |
chr6_-_110500905 | 0.76 |
ENST00000392587.2
|
WASF1
|
WAS protein family, member 1 |
chr6_-_110501200 | 0.75 |
ENST00000392586.1
ENST00000419252.1 ENST00000392589.1 ENST00000392588.1 ENST00000359451.2 |
WASF1
|
WAS protein family, member 1 |
chr9_+_2158443 | 0.74 |
ENST00000302401.3
ENST00000324954.5 ENST00000423555.1 ENST00000382186.1 |
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr10_-_81205373 | 0.72 |
ENST00000372336.3
|
ZCCHC24
|
zinc finger, CCHC domain containing 24 |
chr17_-_38938786 | 0.72 |
ENST00000301656.3
|
KRT27
|
keratin 27 |
chr16_-_89785777 | 0.72 |
ENST00000561976.1
|
VPS9D1
|
VPS9 domain containing 1 |
chr3_-_47324242 | 0.71 |
ENST00000456548.1
ENST00000432493.1 ENST00000335044.2 ENST00000444589.2 |
KIF9
|
kinesin family member 9 |
chr8_-_6420930 | 0.70 |
ENST00000325203.5
|
ANGPT2
|
angiopoietin 2 |
chr15_-_37390482 | 0.70 |
ENST00000559085.1
ENST00000397624.3 |
MEIS2
|
Meis homeobox 2 |
chr3_-_129035120 | 0.68 |
ENST00000333762.4
|
H1FX
|
H1 histone family, member X |
chr4_+_134070439 | 0.67 |
ENST00000264360.5
|
PCDH10
|
protocadherin 10 |
chr2_-_220435963 | 0.67 |
ENST00000373876.1
ENST00000404537.1 ENST00000603926.1 ENST00000373873.4 ENST00000289656.3 |
OBSL1
|
obscurin-like 1 |
chr3_+_141103634 | 0.66 |
ENST00000507722.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
chr12_+_100660909 | 0.66 |
ENST00000549687.1
|
SCYL2
|
SCY1-like 2 (S. cerevisiae) |
chr7_-_86688990 | 0.65 |
ENST00000450689.2
|
KIAA1324L
|
KIAA1324-like |
chr21_-_40032581 | 0.65 |
ENST00000398919.2
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog |
chr11_+_114168773 | 0.65 |
ENST00000542647.1
ENST00000545255.1 |
NNMT
|
nicotinamide N-methyltransferase |
chr19_-_12992244 | 0.65 |
ENST00000538460.1
|
DNASE2
|
deoxyribonuclease II, lysosomal |
chr1_-_151345159 | 0.65 |
ENST00000458566.1
ENST00000447402.3 ENST00000426705.2 ENST00000435071.1 ENST00000368868.5 |
SELENBP1
|
selenium binding protein 1 |
chr6_-_75915757 | 0.65 |
ENST00000322507.8
|
COL12A1
|
collagen, type XII, alpha 1 |
chr12_-_15038779 | 0.65 |
ENST00000228938.5
ENST00000539261.1 |
MGP
|
matrix Gla protein |
chr18_-_52989525 | 0.65 |
ENST00000457482.3
|
TCF4
|
transcription factor 4 |
chr17_+_36584662 | 0.65 |
ENST00000431231.2
ENST00000437668.3 |
ARHGAP23
|
Rho GTPase activating protein 23 |
chr5_-_141249154 | 0.65 |
ENST00000357517.5
ENST00000536585.1 |
PCDH1
|
protocadherin 1 |
chr6_-_31697255 | 0.64 |
ENST00000436437.1
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2 |
chr11_+_114128522 | 0.63 |
ENST00000535401.1
|
NNMT
|
nicotinamide N-methyltransferase |
chr16_+_30662050 | 0.61 |
ENST00000568754.1
|
PRR14
|
proline rich 14 |
chrX_-_70474499 | 0.60 |
ENST00000353904.2
|
ZMYM3
|
zinc finger, MYM-type 3 |
chr6_+_25279651 | 0.60 |
ENST00000329474.6
|
LRRC16A
|
leucine rich repeat containing 16A |
chr14_+_22615942 | 0.59 |
ENST00000390457.2
|
TRAV27
|
T cell receptor alpha variable 27 |
chr16_+_20775358 | 0.59 |
ENST00000440284.2
|
ACSM3
|
acyl-CoA synthetase medium-chain family member 3 |
chr2_+_228678550 | 0.59 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
chr14_+_23846210 | 0.59 |
ENST00000339180.4
ENST00000342473.4 ENST00000397227.3 ENST00000555731.1 |
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5 |
chr19_-_49149553 | 0.58 |
ENST00000084798.4
|
CA11
|
carbonic anhydrase XI |
chr8_+_21916680 | 0.58 |
ENST00000358242.3
ENST00000415253.1 |
DMTN
|
dematin actin binding protein |
chr8_-_93107443 | 0.58 |
ENST00000360348.2
ENST00000520428.1 ENST00000518992.1 ENST00000520556.1 ENST00000518317.1 ENST00000521319.1 ENST00000521375.1 ENST00000518449.1 |
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr12_-_7125770 | 0.58 |
ENST00000261407.4
|
LPCAT3
|
lysophosphatidylcholine acyltransferase 3 |
chr14_+_22985251 | 0.57 |
ENST00000390510.1
|
TRAJ27
|
T cell receptor alpha joining 27 |
chr6_+_86159821 | 0.57 |
ENST00000369651.3
|
NT5E
|
5'-nucleotidase, ecto (CD73) |
chrX_-_45060135 | 0.57 |
ENST00000398000.2
ENST00000377934.4 |
CXorf36
|
chromosome X open reading frame 36 |
chr8_+_70378852 | 0.57 |
ENST00000525061.1
ENST00000458141.2 ENST00000260128.4 |
SULF1
|
sulfatase 1 |
chr8_+_21916710 | 0.57 |
ENST00000523266.1
ENST00000519907.1 |
DMTN
|
dematin actin binding protein |
chr2_+_33359646 | 0.56 |
ENST00000390003.4
ENST00000418533.2 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr3_-_99569821 | 0.56 |
ENST00000487087.1
|
FILIP1L
|
filamin A interacting protein 1-like |
chr11_+_64004888 | 0.56 |
ENST00000541681.1
|
VEGFB
|
vascular endothelial growth factor B |
chr21_+_17792672 | 0.56 |
ENST00000602620.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr11_-_118095718 | 0.55 |
ENST00000526620.1
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
chr14_+_76071805 | 0.55 |
ENST00000539311.1
|
FLVCR2
|
feline leukemia virus subgroup C cellular receptor family, member 2 |
chr1_+_66458072 | 0.54 |
ENST00000423207.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr20_-_23066953 | 0.54 |
ENST00000246006.4
|
CD93
|
CD93 molecule |
chr7_-_22233442 | 0.54 |
ENST00000401957.2
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr8_+_11666649 | 0.53 |
ENST00000528643.1
ENST00000525777.1 |
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1 |
chr15_+_59903975 | 0.53 |
ENST00000560585.1
ENST00000396065.1 |
GCNT3
|
glucosaminyl (N-acetyl) transferase 3, mucin type |
chr6_-_131277510 | 0.53 |
ENST00000525193.1
ENST00000527659.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
chr7_-_120498357 | 0.53 |
ENST00000415871.1
ENST00000222747.3 ENST00000430985.1 |
TSPAN12
|
tetraspanin 12 |
chr12_-_71031185 | 0.52 |
ENST00000548122.1
ENST00000551525.1 ENST00000550358.1 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
chr14_+_24590560 | 0.52 |
ENST00000558325.1
|
RP11-468E2.6
|
RP11-468E2.6 |
chr2_+_63277927 | 0.51 |
ENST00000282549.2
|
OTX1
|
orthodenticle homeobox 1 |
chr12_-_91576561 | 0.50 |
ENST00000547568.2
ENST00000552962.1 |
DCN
|
decorin |
chr5_+_140749803 | 0.50 |
ENST00000576222.1
|
PCDHGB3
|
protocadherin gamma subfamily B, 3 |
chr20_+_62669472 | 0.50 |
ENST00000463337.1
ENST00000358393.1 |
LINC00176
|
long intergenic non-protein coding RNA 176 |
chr2_-_220436248 | 0.50 |
ENST00000265318.4
|
OBSL1
|
obscurin-like 1 |
chr9_+_130860583 | 0.49 |
ENST00000373064.5
|
SLC25A25
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
chr6_+_32146131 | 0.49 |
ENST00000375094.3
|
RNF5
|
ring finger protein 5, E3 ubiquitin protein ligase |
chr17_-_63822563 | 0.49 |
ENST00000317442.8
|
CEP112
|
centrosomal protein 112kDa |
chr1_-_155112883 | 0.49 |
ENST00000368399.1
ENST00000368400.4 ENST00000341298.3 |
DPM3
|
dolichyl-phosphate mannosyltransferase polypeptide 3 |
chrX_-_62974941 | 0.49 |
ENST00000374872.1
ENST00000253401.6 ENST00000374870.4 |
ARHGEF9
|
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
chr9_+_130860810 | 0.49 |
ENST00000433501.1
|
SLC25A25
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
chr11_-_100999775 | 0.49 |
ENST00000263463.5
|
PGR
|
progesterone receptor |
chr1_-_68698197 | 0.48 |
ENST00000370973.2
ENST00000370971.1 |
WLS
|
wntless Wnt ligand secretion mediator |
chr17_+_38599693 | 0.48 |
ENST00000542955.1
ENST00000269593.4 |
IGFBP4
|
insulin-like growth factor binding protein 4 |
chr1_-_110933663 | 0.47 |
ENST00000369781.4
ENST00000541986.1 ENST00000369779.4 |
SLC16A4
|
solute carrier family 16, member 4 |
chr1_-_182361327 | 0.47 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
chr16_+_69221028 | 0.47 |
ENST00000336278.4
|
SNTB2
|
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) |
chr5_+_175223313 | 0.47 |
ENST00000359546.4
|
CPLX2
|
complexin 2 |
chr13_-_29069232 | 0.46 |
ENST00000282397.4
ENST00000541932.1 ENST00000539099.1 |
FLT1
|
fms-related tyrosine kinase 1 |
chr1_-_110933611 | 0.46 |
ENST00000472422.2
ENST00000437429.2 |
SLC16A4
|
solute carrier family 16, member 4 |
chr1_-_153599426 | 0.46 |
ENST00000392622.1
|
S100A13
|
S100 calcium binding protein A13 |
chr6_-_167571817 | 0.46 |
ENST00000366834.1
|
GPR31
|
G protein-coupled receptor 31 |
chr1_-_94586651 | 0.46 |
ENST00000535735.1
ENST00000370225.3 |
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4 |
chr11_+_118401899 | 0.46 |
ENST00000528373.1
ENST00000544878.1 ENST00000354284.4 ENST00000533137.1 ENST00000532762.1 ENST00000526973.1 ENST00000354064.7 ENST00000533102.1 ENST00000313236.5 ENST00000527267.1 ENST00000524725.1 ENST00000533689.1 |
TMEM25
|
transmembrane protein 25 |
chrX_-_19002696 | 0.45 |
ENST00000379942.4
|
PHKA2
|
phosphorylase kinase, alpha 2 (liver) |
chr3_+_100328433 | 0.45 |
ENST00000273352.3
|
GPR128
|
G protein-coupled receptor 128 |
chr6_+_24495067 | 0.45 |
ENST00000357578.3
ENST00000546278.1 ENST00000491546.1 |
ALDH5A1
|
aldehyde dehydrogenase 5 family, member A1 |
chr5_-_88178964 | 0.45 |
ENST00000513252.1
ENST00000508569.1 ENST00000510942.1 ENST00000506554.1 |
MEF2C
|
myocyte enhancer factor 2C |
chr18_+_9334755 | 0.45 |
ENST00000262120.5
|
TWSG1
|
twisted gastrulation BMP signaling modulator 1 |
chr21_+_47706537 | 0.45 |
ENST00000397691.1
|
YBEY
|
ybeY metallopeptidase (putative) |
chr5_-_35230434 | 0.45 |
ENST00000504500.1
|
PRLR
|
prolactin receptor |
chr8_-_101321584 | 0.45 |
ENST00000523167.1
|
RNF19A
|
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
chr19_-_15235906 | 0.44 |
ENST00000600984.1
|
ILVBL
|
ilvB (bacterial acetolactate synthase)-like |
chr3_-_195538760 | 0.44 |
ENST00000475231.1
|
MUC4
|
mucin 4, cell surface associated |
chr12_+_58087901 | 0.44 |
ENST00000315970.7
ENST00000547079.1 ENST00000439210.2 ENST00000389146.6 ENST00000413095.2 ENST00000551035.1 ENST00000257966.8 ENST00000435406.2 ENST00000550372.1 ENST00000389142.5 |
OS9
|
osteosarcoma amplified 9, endoplasmic reticulum lectin |
chr8_+_1993152 | 0.44 |
ENST00000262113.4
|
MYOM2
|
myomesin 2 |
chr11_-_118095801 | 0.44 |
ENST00000356289.5
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
chr1_-_85870177 | 0.44 |
ENST00000542148.1
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
chrX_-_48815633 | 0.44 |
ENST00000428668.2
|
OTUD5
|
OTU domain containing 5 |
chr15_+_81293254 | 0.43 |
ENST00000267984.2
|
MESDC1
|
mesoderm development candidate 1 |
chr8_-_4851937 | 0.43 |
ENST00000537824.1
ENST00000542608.1 ENST00000539096.1 |
CSMD1
|
CUB and Sushi multiple domains 1 |
chr17_+_67498538 | 0.43 |
ENST00000589647.1
|
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
chr20_-_33732952 | 0.43 |
ENST00000541621.1
|
EDEM2
|
ER degradation enhancer, mannosidase alpha-like 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 15.8 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
1.5 | 12.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.0 | 4.1 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
1.0 | 3.0 | GO:2000006 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
1.0 | 2.9 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.7 | 23.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.7 | 2.7 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.5 | 1.6 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) smooth muscle hyperplasia(GO:0014806) |
0.5 | 1.4 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.4 | 1.7 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.4 | 1.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.4 | 1.2 | GO:0002194 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.4 | 1.5 | GO:0090107 | aminophospholipid transport(GO:0015917) regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.4 | 2.6 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.3 | 1.4 | GO:0003409 | optic cup structural organization(GO:0003409) |
0.3 | 1.0 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.3 | 0.9 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.3 | 7.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 1.7 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.3 | 0.8 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 1.0 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.2 | 2.3 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.2 | 1.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 1.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 1.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 0.8 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.2 | 0.8 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.2 | 0.6 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.2 | 1.1 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.2 | 0.8 | GO:0006272 | leading strand elongation(GO:0006272) |
0.2 | 0.6 | GO:0070666 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.2 | 0.9 | GO:0060301 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.2 | 0.5 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
0.2 | 4.0 | GO:0072189 | ureter development(GO:0072189) |
0.2 | 1.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 0.3 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.2 | 0.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 1.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 1.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.4 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.1 | 0.6 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.1 | 0.4 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 | 0.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 1.0 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.4 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.1 | 2.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 1.3 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.5 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.4 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.1 | 2.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 1.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.3 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.1 | 3.5 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.3 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 0.4 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.1 | 0.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.1 | 0.5 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.1 | 0.4 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.1 | 0.3 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.1 | 0.7 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) response to aldosterone(GO:1904044) |
0.1 | 0.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.3 | GO:2000777 | endomitotic cell cycle(GO:0007113) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.1 | 0.3 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.1 | 0.6 | GO:0009450 | acetate metabolic process(GO:0006083) gamma-aminobutyric acid catabolic process(GO:0009450) |
0.1 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 1.1 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.1 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.1 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 1.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.7 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 0.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.5 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 0.2 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.1 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 2.6 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 1.3 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 0.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 1.2 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 0.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.4 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.3 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.1 | 1.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.1 | 0.4 | GO:1902847 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.1 | 0.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.3 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.1 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.1 | 0.3 | GO:1903336 | positive regulation of protein autoubiquitination(GO:1902499) regulation of late endosome to lysosome transport(GO:1902822) negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.6 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.5 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.3 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 1.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.4 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
0.1 | 0.3 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.1 | 0.1 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
0.1 | 0.3 | GO:1903758 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.1 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.3 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.1 | 0.3 | GO:0070543 | response to linoleic acid(GO:0070543) |
0.1 | 0.1 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 1.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.1 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.0 | 0.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 1.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 0.5 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 1.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.1 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.3 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.0 | 1.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.0 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.2 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.0 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.0 | 0.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.2 | GO:0071874 | axon midline choice point recognition(GO:0016199) cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 1.2 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.3 | GO:0071651 | mature ribosome assembly(GO:0042256) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.5 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.0 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.0 | 0.1 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.0 | 0.4 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.0 | 0.1 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.6 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.0 | 0.1 | GO:0018032 | protein amidation(GO:0018032) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 1.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.8 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.2 | GO:2001181 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 1.1 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.2 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:1990834 | response to odorant(GO:1990834) |
0.0 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 1.0 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.1 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.0 | 0.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.3 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.2 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.4 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.2 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.1 | GO:0015862 | uridine transport(GO:0015862) |
0.0 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:2001191 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) negative regulation of dendritic cell apoptotic process(GO:2000669) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
0.0 | 0.1 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.0 | 0.6 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.2 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.1 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.0 | 0.2 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 1.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.0 | GO:0060221 | retinal rod cell differentiation(GO:0060221) positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.3 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.0 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.0 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.0 | 0.1 | GO:0019085 | early viral transcription(GO:0019085) |
0.0 | 0.5 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.1 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 0.5 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.0 | 0.1 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.0 | 0.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.5 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.0 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 1.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.5 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.1 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.0 | 0.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.4 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.0 | 0.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.1 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.0 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.5 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.0 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.0 | 0.1 | GO:0060355 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.2 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.0 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.0 | 0.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.1 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.2 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.0 | 0.1 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 1.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.1 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.0 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.5 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 7.7 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.6 | 16.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.6 | 2.9 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.3 | 1.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.2 | 1.2 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.4 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.1 | 0.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 2.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.1 | 0.3 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.1 | 0.3 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 1.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 2.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
0.1 | 0.3 | GO:0044753 | amphisome(GO:0044753) |
0.1 | 0.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 2.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.4 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 37.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
0.1 | 1.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.9 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 1.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 1.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 1.0 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 1.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 1.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.8 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.4 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 2.5 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 1.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.6 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.0 | 0.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 2.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.2 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 1.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.7 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 1.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 1.9 | GO:0005795 | Golgi stack(GO:0005795) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 22.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.7 | 12.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 16.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 1.5 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.5 | 2.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.5 | 2.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.5 | 2.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 2.5 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.4 | 1.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 1.0 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.3 | 1.3 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.3 | 1.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 7.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 0.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.3 | 1.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 1.3 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.2 | 2.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 1.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 0.8 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.6 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.2 | 2.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 2.3 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 0.5 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.2 | 0.5 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.2 | 1.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.2 | 0.5 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.1 | 0.8 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.5 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 1.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 0.4 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.1 | 1.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.3 | GO:0047977 | linoleate 13S-lipoxygenase activity(GO:0016165) hepoxilin-epoxide hydrolase activity(GO:0047977) |
0.1 | 0.9 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.3 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.1 | 0.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 2.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.4 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 0.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 2.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 2.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 1.2 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 0.6 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 1.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.5 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.1 | 1.5 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.1 | 0.6 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.6 | GO:0009374 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
0.1 | 0.3 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.1 | 0.3 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.1 | 0.2 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.1 | 0.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 4.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.0 | 0.2 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.0 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.1 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.0 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.2 | GO:0016624 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
0.0 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.3 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.0 | 0.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.0 | 0.1 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.0 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 1.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.1 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 1.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) interleukin-7 receptor activity(GO:0004917) |
0.0 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.1 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 0.1 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.0 | 0.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 1.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.0 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.0 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 1.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 0.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 7.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.2 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.0 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.8 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.1 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.0 | 0.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0032408 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 3.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 3.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 6.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 6.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 3.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 2.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 1.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 2.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 2.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 1.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.3 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 3.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 15.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 2.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 2.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 5.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 4.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 4.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 2.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 2.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.8 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 2.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.8 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 1.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 1.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 1.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.1 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.7 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.5 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.6 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |